1 Min Read
Jan 2 (Reuters) - Trevena Inc:
* TREVENA ANNOUNCES FDA ACCEPTANCE FOR REVIEW OF NEW DRUG APPLICATION FOR OLINVO (OLICERIDINE) INJECTION
* SAYS EXPECTS THAT PDUFA DATE FOR NDA WILL BE IN Q4 OF 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.